| Matthew Hoggatt, MD | |
|
250 Blossom St, Suite 220, Webster, TX 77598 | |
| (281) 332-0202 | |
| (281) 332-5266 |
| Full Name | Matthew Hoggatt |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 23 Years |
| Location | 250 Blossom St, Webster, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285646471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | M4163 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Houston Physicians' Hospital | Webster, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
"In sharp contrast to how he got elected, President Barack Obama is bashing Republicans this week while urging Democrats to unite behind his effort to reform the nation's healthcare system," The Hill reports. "Months after some Democrats on and off Capitol Hill were suggesting that healthcare reform could attract 70 to 80 votes in the Senate, Obama and congressional leaders are focused on uniting their party and picking up, at most, a couple GOP defectors to help clear the 60-vote hurdle in the upper chamber."
Dopamine agonists are increasingly used to treat people with Parkinson's disease, but there is a debate about how well they work.
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.
In a recent bioRxiv preprint paper, researchers from the Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, and Department of Global Health, University of Washington, Seattle, WA, discuss their study in mice that undergo detailed immunophenotyping before getting infected with SARS-CoV.
The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called "liberation therapy" or the "liberation procedure" to treat chronic cerebrospinal venous insufficiency (CCSVI).
› Verified 7 days ago
| Entity Name | Memorial Hermann Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
"In sharp contrast to how he got elected, President Barack Obama is bashing Republicans this week while urging Democrats to unite behind his effort to reform the nation's healthcare system," The Hill reports. "Months after some Democrats on and off Capitol Hill were suggesting that healthcare reform could attract 70 to 80 votes in the Senate, Obama and congressional leaders are focused on uniting their party and picking up, at most, a couple GOP defectors to help clear the 60-vote hurdle in the upper chamber."
Dopamine agonists are increasingly used to treat people with Parkinson's disease, but there is a debate about how well they work.
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.
In a recent bioRxiv preprint paper, researchers from the Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, and Department of Global Health, University of Washington, Seattle, WA, discuss their study in mice that undergo detailed immunophenotyping before getting infected with SARS-CoV.
The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called "liberation therapy" or the "liberation procedure" to treat chronic cerebrospinal venous insufficiency (CCSVI).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Hoggatt, MD 250 Blossom St, Ste 220, Webster, TX 77598-4243 Ph: (281) 332-0202 | Matthew Hoggatt, MD 250 Blossom St, Suite 220, Webster, TX 77598 Ph: (281) 332-0202 |
News Archive
"In sharp contrast to how he got elected, President Barack Obama is bashing Republicans this week while urging Democrats to unite behind his effort to reform the nation's healthcare system," The Hill reports. "Months after some Democrats on and off Capitol Hill were suggesting that healthcare reform could attract 70 to 80 votes in the Senate, Obama and congressional leaders are focused on uniting their party and picking up, at most, a couple GOP defectors to help clear the 60-vote hurdle in the upper chamber."
Dopamine agonists are increasingly used to treat people with Parkinson's disease, but there is a debate about how well they work.
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.
In a recent bioRxiv preprint paper, researchers from the Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, and Department of Global Health, University of Washington, Seattle, WA, discuss their study in mice that undergo detailed immunophenotyping before getting infected with SARS-CoV.
The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called "liberation therapy" or the "liberation procedure" to treat chronic cerebrospinal venous insufficiency (CCSVI).
› Verified 7 days ago
Dr. Nathaniel L Barnes, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 250 Blossom St, Suite 220, Webster, TX 77598 Phone: 281-332-0202 Fax: 281-332-0202 | |
Dr. Jeromy T Hackney, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 150 E Medical Center Blvd Ste C, Webster, TX 77598 Phone: 281-316-4978 | |
Dr. James E Morneau, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 17099 Texas Ave, Suite 400, Webster, TX 77598 Phone: 281-338-1668 Fax: 281-316-1118 | |
Dr. Thanh A Nguyen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 250 Blossom St, Suite 220, Webster, TX 77598 Phone: 281-332-0202 Fax: 281-332-5266 | |
Dr. Rohit Robert Dhir, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 600 N Kobayashi Ste 210, Webster, TX 77598 Phone: 281-946-6462 Fax: 281-336-1181 | |
Dr. Douglas S Dow, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 250 Blossom St, Suite 220, Webster, TX 77598 Phone: 281-332-0202 Fax: 281-332-5266 |